The Team

Eric Converse is AMRA’s Chief Executive Officer. Before joining AMRA, Eric spent three years as President and CEO of VirtualScopics, an Imaging Contract Research Organization (iCRO), which under his direction grew exponentially before being acquired by the leading imaging and cardiac core laboratory, BioTelemetry Research. Most recently, Eric has been working with large pharmaceutical companies on potential and current investments and projects focused on real-world data (RWD) and real-world evidence (RWE). In addition to a specialty in uniting international teams to meet and exceed customer requirements, Eric has over 15 years of further experience holding multiple CEO roles and Board positions across a variety of companies and industries in the US and Europe.

Olof Dahlqvist Leinhard is the Chief Scientific Officer, responsible for AMRA’s technical vision, for leading the execution of technology platforms and partnership strategies, and for overseeing all technology research and product development. Olof is also a Founder and Member of the Board.

Since 2012, Olof has performed as a Senior University Lecturer in Magnetic Resonance (MR) Physics at Linköping University (LiU), within the Department of Medicine and Health (IMH) / Division of Radiological Sciences (RAD). His position has included the PhD supervision of five PhD candidates, as well as the student supervision of over 20 individuals within MR Physics and Radiology. From 2010 to 2014, Olof also served as the Director of Doctoral Studies at the Center for Medical Image Science and Visualization (CMIV).

Renowned within the field of MR Physics, Olof has over 45 peer-reviewed journal and conference articles, as well as over 90 peer-reviewed conference abstracts to his name. Olof earned a PhD in Medical Radiation Physics at LiU in 2010, following a Licentiate Degree in Medicine in 2008, and a Master of Science in Physics in 2004.

Olof currently holds the following assignments:

• Member of the Scientific Council of CMIV
• Member of the Board of SMIL, a network for SMEs in Linköping
• Examiner / Course Coordinator for Molecular Imaging 7.5 Hp, Advanced Level
• Member of the International Society for Magnetic Resonance in Medicine
• Reviewer for European Radiology and European Journal of Radiology

Magnus Borga operates as AMRA’s Chief Technology Officer, concentrating on national and international strategic research collaborations, publication and grant policy, coordination of collaborative AMRA-CMIV research, and medical image analysis implementation into AMRA.

Magnus is also a Founder and Member of the Board.

Magnus serves as Professor in Medical Informatics within the Department of Biomedical Engineering, and as Associate Dean at the Faculty of Science and Engineering (Institute of Technology), Linköping University (LiU), Sweden.

Over the course of two decades, Magnus has developed his career at LiU, earning a M.Sc. in Applied Physics and Electrical Engineering in 1991, a Ph.D. in Image Processing in 1998, and a Docent in Medical Informatics in 2005. He began as a Research Assistant within the Department of Electrical Engineering at LiU in 1998, transitioning into the Department of Biomedical Engineering, where he was later appointed Head of the Department.

Magnus holds the following national and international assignments:

• Member of the Board, Swedish Society for Automated Image Analysis, 2000 – 2015
• Member of the Scientific Council of the Center for Medical Image Science and Visualization (CMIV), 2004 – current
• Member of the Governing Board of The International Association for Pattern Recognition (IAPR), 2006 – 2014
• General Chair for the International Conference on Pattern Recognition (ICPR) 2014
• President, Swedish Society for Automated Image Analysis (SSBA), 2006 – 2010

Klas Themner has, as AMRA’s Chief Operating Officer, overall responsibility for the Product Development and Operations. In this role, he is responsible for the company’s product road map and the planning of product realization and service provision. Klas has 20 years of experience as COO & CFO in three different listed medical device companies, all within advanced medical image processing and across all imaging modalities. Most recently Klas has been working in a Pharma subsidiary focused on medical image analysis for prostate cancer applications. Before entering into Life Science he spent 10 years within the Swedish defense industry. He has an engineering background and received a PhD in Nuclear Physics at Lund University.

Janne West operates as AMRA’s Chief Quality Officer, with responsibility for the development and implementation of a Quality Management System, as well as national and international regulatory compliance and approvals.

Janne is a part-time lecturer at Linköping University and is working as a postdoctoral researcher at the Department of Medicine and Health Sciences (IMH), focusing largely upon whole-body fat and water imaging.

He previously worked as the Development Manager for Synthetic MR AB from 2007-2014, where he was responsible for a development team, as well as regulatory compliance and approvals for medical devices.

In 2014, Janne earned his Ph.D. in Medical Sciences at IMH, Linköping University (LiU). Throughout the course of his research, he has presented at approximately 15 international conferences and, with several peer-reviewed articles and a completed thesis, ”Quantitative MRI of the Brain,” he has established his expertise within MR Physics and Quantitative MRI, particularly within tissue segmentation and Multiple Sclerosis. Janne previously received his M.Sc. in Computer Science and Engineering in 2007, with a specialization in Medical Imaging from LiU.

As Senior Financial Advisor, Ms. Robbins combines financial discipline with creative commercial strategy to expand the applications of AMRA’s novel imaging analytics software. She draws on her extensive experience as both a health care investor and operator. During her time at several healthcare-focused investment funds, including Genzyme Ventures, Tullis Health Investors, and Paramount Capital, she completed eight venture capital investments in transformative medical technologies resulting in six IPOs and two M&A transactions and several products on the market or in late-stage clinical development.

Ms. Robbins has also worked on behalf of numerous operating companies to craft strategy, develop long-range financial forecasts, negotiate transactions, and advance fundraising efforts. In addition, Ms. Robbins has served in foundational operating roles with a U.S.-based direct-pay primary care practice and a health tech SaaS start-up. Her recent work with large pharmaceutical companies centers on the commercial and research applications of real-world data (RWD) and modern analytics in the medical field.

Ms. Robbins received her MBA with Honors from The Wharton School in Health Care Management and Finance, and her BA, Summa Cum Laude, in Biochemistry and Economics from Dartmouth College. She is a CFA® charterholder.